Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Spinal Neoplasms | 55 | 2023 | 760 | 10.980 |
Why?
|
Spinal Fusion | 26 | 2023 | 1241 | 5.840 |
Why?
|
Spinal Cord Neoplasms | 16 | 2023 | 281 | 3.590 |
Why?
|
Spine | 22 | 2024 | 1144 | 2.010 |
Why?
|
Spondylolisthesis | 5 | 2022 | 163 | 1.890 |
Why?
|
Neurosurgical Procedures | 18 | 2023 | 2002 | 1.840 |
Why?
|
Spinal Cord Diseases | 9 | 2023 | 298 | 1.770 |
Why?
|
Spinal Diseases | 6 | 2023 | 538 | 1.760 |
Why?
|
Cervical Vertebrae | 13 | 2023 | 976 | 1.620 |
Why?
|
Thoracic Vertebrae | 11 | 2023 | 608 | 1.600 |
Why?
|
Surgery, Computer-Assisted | 4 | 2021 | 1018 | 1.460 |
Why?
|
Radiosurgery | 11 | 2022 | 1329 | 1.420 |
Why?
|
Lumbar Vertebrae | 12 | 2023 | 1848 | 1.410 |
Why?
|
Chondrosarcoma | 4 | 2024 | 309 | 1.210 |
Why?
|
Sarcopenia | 2 | 2023 | 368 | 1.170 |
Why?
|
Bone Transplantation | 3 | 2020 | 907 | 1.140 |
Why?
|
Spinal Cord Compression | 4 | 2023 | 235 | 1.080 |
Why?
|
Chordoma | 7 | 2024 | 359 | 1.070 |
Why?
|
Postoperative Complications | 29 | 2023 | 15297 | 0.930 |
Why?
|
Laminectomy | 3 | 2013 | 234 | 0.870 |
Why?
|
Decompression, Surgical | 8 | 2023 | 594 | 0.820 |
Why?
|
Carcinoma, Renal Cell | 4 | 2024 | 3143 | 0.700 |
Why?
|
Radiculopathy | 1 | 2021 | 197 | 0.670 |
Why?
|
Hemostatic Techniques | 1 | 2020 | 116 | 0.670 |
Why?
|
Sacrum | 7 | 2022 | 288 | 0.660 |
Why?
|
Ketones | 1 | 2020 | 188 | 0.650 |
Why?
|
Zygapophyseal Joint | 1 | 2020 | 129 | 0.650 |
Why?
|
Teriparatide | 1 | 2020 | 225 | 0.630 |
Why?
|
Tranexamic Acid | 1 | 2020 | 146 | 0.620 |
Why?
|
Osteotomy | 2 | 2022 | 822 | 0.600 |
Why?
|
Antifibrinolytic Agents | 1 | 2020 | 254 | 0.600 |
Why?
|
Ossification of Posterior Longitudinal Ligament | 2 | 2020 | 19 | 0.580 |
Why?
|
Ilium | 2 | 2020 | 154 | 0.560 |
Why?
|
Kidney Neoplasms | 3 | 2022 | 4262 | 0.550 |
Why?
|
Osteosarcoma | 2 | 2024 | 881 | 0.550 |
Why?
|
Hernia | 2 | 2019 | 71 | 0.530 |
Why?
|
Prostheses and Implants | 1 | 2023 | 1387 | 0.530 |
Why?
|
Retrospective Studies | 50 | 2024 | 77460 | 0.520 |
Why?
|
Adrenocortical Carcinoma | 1 | 2016 | 88 | 0.510 |
Why?
|
Humans | 136 | 2024 | 744366 | 0.500 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 642 | 0.500 |
Why?
|
Polyethylene Glycols | 1 | 2020 | 1182 | 0.480 |
Why?
|
Adrenal Cortex Neoplasms | 1 | 2016 | 162 | 0.480 |
Why?
|
Bone Screws | 2 | 2021 | 520 | 0.470 |
Why?
|
Carcinoid Tumor | 1 | 2015 | 235 | 0.470 |
Why?
|
Scoliosis | 1 | 2020 | 725 | 0.440 |
Why?
|
Bone Density Conservation Agents | 1 | 2020 | 772 | 0.440 |
Why?
|
Robotics | 1 | 2020 | 899 | 0.440 |
Why?
|
Neurosurgery | 3 | 2023 | 643 | 0.420 |
Why?
|
Blood | 1 | 2014 | 598 | 0.420 |
Why?
|
Nervous System Diseases | 1 | 2022 | 1622 | 0.400 |
Why?
|
Dura Mater | 3 | 2021 | 291 | 0.400 |
Why?
|
Thoracotomy | 1 | 2013 | 363 | 0.390 |
Why?
|
Osteoporosis | 1 | 2020 | 1579 | 0.370 |
Why?
|
Glossopharyngeal Nerve Diseases | 1 | 2009 | 11 | 0.360 |
Why?
|
Glossopharyngeal Nerve | 1 | 2009 | 18 | 0.360 |
Why?
|
Prognosis | 15 | 2023 | 29060 | 0.360 |
Why?
|
Meningioma | 3 | 2023 | 1209 | 0.340 |
Why?
|
Treatment Outcome | 32 | 2023 | 63107 | 0.340 |
Why?
|
Meningeal Neoplasms | 3 | 2023 | 1241 | 0.330 |
Why?
|
Spinal Curvatures | 2 | 2020 | 66 | 0.330 |
Why?
|
Skull Base Neoplasms | 2 | 2023 | 284 | 0.320 |
Why?
|
Nerve Compression Syndromes | 1 | 2009 | 160 | 0.320 |
Why?
|
Spinal Fractures | 4 | 2020 | 696 | 0.310 |
Why?
|
Neural Tube Defects | 1 | 2010 | 256 | 0.310 |
Why?
|
Spinal Cord Vascular Diseases | 1 | 2017 | 11 | 0.300 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3524 | 0.290 |
Why?
|
Middle Aged | 43 | 2022 | 213390 | 0.290 |
Why?
|
Adult | 44 | 2023 | 214052 | 0.280 |
Why?
|
Fractures, Compression | 3 | 2019 | 133 | 0.280 |
Why?
|
Artificial Intelligence | 4 | 2024 | 2213 | 0.280 |
Why?
|
Neoplasms | 5 | 2023 | 21696 | 0.280 |
Why?
|
Spinal Cord | 5 | 2021 | 1810 | 0.270 |
Why?
|
Analgesics, Opioid | 4 | 2022 | 3677 | 0.270 |
Why?
|
Arthroplasty | 3 | 2023 | 305 | 0.260 |
Why?
|
Length of Stay | 10 | 2023 | 6311 | 0.260 |
Why?
|
Breast Neoplasms | 2 | 2023 | 20824 | 0.260 |
Why?
|
Central Nervous System Vascular Malformations | 1 | 2017 | 145 | 0.260 |
Why?
|
Lung Neoplasms | 4 | 2019 | 13104 | 0.250 |
Why?
|
Bone Neoplasms | 3 | 2024 | 2530 | 0.240 |
Why?
|
Tomography, X-Ray Computed | 4 | 2019 | 20130 | 0.240 |
Why?
|
Patient Readmission | 5 | 2021 | 3116 | 0.240 |
Why?
|
Spinal Osteophytosis | 1 | 2023 | 29 | 0.240 |
Why?
|
Diskectomy | 5 | 2023 | 206 | 0.240 |
Why?
|
Algorithms | 4 | 2020 | 13882 | 0.230 |
Why?
|
Lymphocyte Activation | 1 | 2014 | 5524 | 0.230 |
Why?
|
Aged | 31 | 2022 | 163288 | 0.230 |
Why?
|
Cutis Laxa | 1 | 2023 | 29 | 0.230 |
Why?
|
Female | 46 | 2024 | 380193 | 0.230 |
Why?
|
Male | 49 | 2024 | 350115 | 0.230 |
Why?
|
Spondylosis | 1 | 2023 | 81 | 0.220 |
Why?
|
Obesity | 2 | 2023 | 12746 | 0.200 |
Why?
|
Chemokine CCL20 | 1 | 2021 | 65 | 0.200 |
Why?
|
Immunotherapy | 1 | 2017 | 4446 | 0.200 |
Why?
|
Specialties, Surgical | 2 | 2024 | 391 | 0.200 |
Why?
|
Receptors, CCR6 | 1 | 2021 | 81 | 0.200 |
Why?
|
B-Lymphocytes | 1 | 2014 | 4666 | 0.200 |
Why?
|
Neoplasm Metastasis | 3 | 2022 | 4851 | 0.200 |
Why?
|
Microsurgery | 1 | 2017 | 796 | 0.190 |
Why?
|
Wound Infection | 1 | 2023 | 242 | 0.190 |
Why?
|
Astrocytoma | 2 | 2016 | 790 | 0.190 |
Why?
|
Blood Patch, Epidural | 1 | 2021 | 59 | 0.190 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 2 | 2018 | 1692 | 0.190 |
Why?
|
Salvage Therapy | 2 | 2019 | 1275 | 0.190 |
Why?
|
Brain Neoplasms | 1 | 2022 | 8861 | 0.190 |
Why?
|
Glioblastoma | 1 | 2016 | 3481 | 0.190 |
Why?
|
Benzophenones | 1 | 2020 | 57 | 0.180 |
Why?
|
Pseudarthrosis | 1 | 2020 | 59 | 0.180 |
Why?
|
Lumbosacral Region | 1 | 2021 | 310 | 0.180 |
Why?
|
Ultrasonics | 1 | 2021 | 212 | 0.180 |
Why?
|
Pressure | 1 | 2023 | 1203 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 2 | 2018 | 5534 | 0.170 |
Why?
|
Bone Cements | 1 | 2021 | 325 | 0.170 |
Why?
|
Survival Analysis | 6 | 2023 | 10252 | 0.170 |
Why?
|
Injections, Subcutaneous | 1 | 2020 | 667 | 0.170 |
Why?
|
Surgical Wound Infection | 2 | 2020 | 1540 | 0.170 |
Why?
|
Bone Density | 2 | 2023 | 3468 | 0.160 |
Why?
|
Melanoma | 1 | 2017 | 5511 | 0.160 |
Why?
|
Lordosis | 1 | 2019 | 84 | 0.160 |
Why?
|
Postoperative Nausea and Vomiting | 1 | 2019 | 119 | 0.160 |
Why?
|
Mood Disorders | 2 | 2022 | 1106 | 0.160 |
Why?
|
Patient Discharge | 2 | 2021 | 3318 | 0.160 |
Why?
|
Hospital Costs | 2 | 2022 | 985 | 0.160 |
Why?
|
Neck Pain | 1 | 2019 | 180 | 0.160 |
Why?
|
Administration, Topical | 1 | 2020 | 690 | 0.160 |
Why?
|
Antiemetics | 1 | 2019 | 177 | 0.150 |
Why?
|
Evoked Potentials, Motor | 1 | 2020 | 454 | 0.150 |
Why?
|
Early Diagnosis | 1 | 2022 | 1184 | 0.150 |
Why?
|
Spinal Nerve Roots | 1 | 2017 | 121 | 0.150 |
Why?
|
Spinal Stenosis | 1 | 2020 | 255 | 0.150 |
Why?
|
Embolization, Therapeutic | 1 | 2017 | 1392 | 0.150 |
Why?
|
Serum Albumin | 1 | 2020 | 675 | 0.140 |
Why?
|
Insulin Infusion Systems | 1 | 2018 | 212 | 0.140 |
Why?
|
Anesthetics, Intravenous | 1 | 2020 | 417 | 0.140 |
Why?
|
Aged, 80 and over | 10 | 2022 | 57776 | 0.140 |
Why?
|
Alkaline Phosphatase | 1 | 2020 | 867 | 0.140 |
Why?
|
Health Care Rationing | 1 | 2020 | 437 | 0.140 |
Why?
|
Quality of Life | 6 | 2022 | 12802 | 0.140 |
Why?
|
Orthopedic Procedures | 3 | 2017 | 1289 | 0.140 |
Why?
|
Spinal Injuries | 1 | 2020 | 301 | 0.140 |
Why?
|
Deglutition Disorders | 1 | 2022 | 606 | 0.140 |
Why?
|
Anesthesia, General | 2 | 2020 | 1171 | 0.130 |
Why?
|
Joint Instability | 1 | 2023 | 792 | 0.130 |
Why?
|
Karnofsky Performance Status | 1 | 2016 | 173 | 0.130 |
Why?
|
Free Tissue Flaps | 1 | 2020 | 328 | 0.130 |
Why?
|
Cluster Analysis | 1 | 2023 | 2715 | 0.130 |
Why?
|
Epidural Space | 1 | 2016 | 124 | 0.130 |
Why?
|
Muscle Weakness | 2 | 2017 | 413 | 0.130 |
Why?
|
Blood Loss, Surgical | 1 | 2020 | 662 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2018 | 647 | 0.130 |
Why?
|
Brain Concussion | 2 | 2021 | 1320 | 0.130 |
Why?
|
Osteoporotic Fractures | 1 | 2020 | 401 | 0.130 |
Why?
|
Survival Rate | 4 | 2019 | 12788 | 0.130 |
Why?
|
Malnutrition | 1 | 2021 | 625 | 0.130 |
Why?
|
Transplantation, Autologous | 1 | 2020 | 2124 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2018 | 578 | 0.120 |
Why?
|
Hospitals | 6 | 2023 | 3954 | 0.120 |
Why?
|
Hemangioblastoma | 1 | 2014 | 70 | 0.120 |
Why?
|
Osteophyte | 1 | 2014 | 45 | 0.120 |
Why?
|
Combined Modality Therapy | 2 | 2017 | 8642 | 0.120 |
Why?
|
Calcinosis | 1 | 2023 | 1499 | 0.120 |
Why?
|
Catheterization | 1 | 2019 | 1470 | 0.120 |
Why?
|
Propofol | 1 | 2020 | 629 | 0.120 |
Why?
|
Patients | 1 | 2020 | 900 | 0.120 |
Why?
|
Leadership | 1 | 2023 | 1357 | 0.120 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 290 | 0.110 |
Why?
|
Endovascular Procedures | 1 | 2017 | 1980 | 0.110 |
Why?
|
Rats, Inbred Lew | 1 | 2014 | 1162 | 0.110 |
Why?
|
Credentialing | 1 | 2013 | 126 | 0.110 |
Why?
|
Kaplan-Meier Estimate | 3 | 2018 | 6539 | 0.110 |
Why?
|
Central Nervous System Neoplasms | 1 | 2021 | 895 | 0.110 |
Why?
|
Pelvis | 2 | 2019 | 730 | 0.110 |
Why?
|
Polymers | 1 | 2020 | 1621 | 0.110 |
Why?
|
Up-Regulation | 1 | 2021 | 4222 | 0.100 |
Why?
|
Ependymoma | 1 | 2015 | 334 | 0.100 |
Why?
|
Coronavirus Infections | 2 | 2020 | 3135 | 0.100 |
Why?
|
Pneumonia, Viral | 2 | 2020 | 3242 | 0.100 |
Why?
|
Neoplasm Recurrence, Local | 4 | 2021 | 9240 | 0.100 |
Why?
|
Posture | 2 | 2019 | 958 | 0.100 |
Why?
|
Patient Acceptance of Health Care | 2 | 2022 | 3020 | 0.100 |
Why?
|
Risk Factors | 11 | 2023 | 72296 | 0.100 |
Why?
|
Longitudinal Ligaments | 1 | 2011 | 27 | 0.100 |
Why?
|
Self-Assessment | 2 | 2023 | 390 | 0.100 |
Why?
|
Brown-Sequard Syndrome | 1 | 2010 | 4 | 0.100 |
Why?
|
Paraparesis, Spastic | 1 | 2010 | 8 | 0.100 |
Why?
|
Back Pain | 1 | 2015 | 545 | 0.090 |
Why?
|
Neuronavigation | 1 | 2012 | 167 | 0.090 |
Why?
|
Inpatients | 4 | 2022 | 2518 | 0.090 |
Why?
|
Hypesthesia | 2 | 2023 | 109 | 0.090 |
Why?
|
Meningocele | 1 | 2010 | 45 | 0.090 |
Why?
|
Education, Medical | 1 | 2022 | 1722 | 0.090 |
Why?
|
Nutritional Status | 3 | 2023 | 1609 | 0.090 |
Why?
|
Young Adult | 9 | 2023 | 56429 | 0.090 |
Why?
|
Pandemics | 2 | 2020 | 8385 | 0.090 |
Why?
|
Follow-Up Studies | 9 | 2023 | 39052 | 0.090 |
Why?
|
Cerebellar Neoplasms | 1 | 2014 | 587 | 0.090 |
Why?
|
Sarcoma | 1 | 2021 | 1897 | 0.090 |
Why?
|
Pain, Postoperative | 1 | 2019 | 1643 | 0.090 |
Why?
|
Radiotherapy | 1 | 2016 | 1533 | 0.090 |
Why?
|
Disease Progression | 3 | 2017 | 13286 | 0.090 |
Why?
|
Patient Care Team | 1 | 2021 | 2531 | 0.090 |
Why?
|
Adolescent | 11 | 2023 | 85779 | 0.090 |
Why?
|
Decision Making | 2 | 2020 | 3888 | 0.090 |
Why?
|
Risk Assessment | 3 | 2022 | 23336 | 0.090 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2018 | 2455 | 0.080 |
Why?
|
Software | 1 | 2023 | 4441 | 0.080 |
Why?
|
England | 2 | 2021 | 522 | 0.080 |
Why?
|
Lymphocyte Count | 2 | 2023 | 793 | 0.080 |
Why?
|
Students, Medical | 1 | 2022 | 1862 | 0.080 |
Why?
|
Delphi Technique | 2 | 2023 | 779 | 0.080 |
Why?
|
Structure-Activity Relationship | 1 | 2014 | 3130 | 0.080 |
Why?
|
Brain Injuries | 1 | 2021 | 2029 | 0.080 |
Why?
|
Recovery of Function | 2 | 2016 | 2926 | 0.080 |
Why?
|
Facial Pain | 1 | 2009 | 127 | 0.080 |
Why?
|
Age Factors | 3 | 2020 | 18373 | 0.080 |
Why?
|
Patient Selection | 1 | 2020 | 4216 | 0.080 |
Why?
|
North America | 2 | 2023 | 1249 | 0.080 |
Why?
|
Comorbidity | 3 | 2022 | 10388 | 0.080 |
Why?
|
Diagnostic Imaging | 1 | 2022 | 3508 | 0.080 |
Why?
|
Logistic Models | 2 | 2020 | 13409 | 0.080 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2017 | 1378 | 0.070 |
Why?
|
Protons | 2 | 2023 | 1127 | 0.070 |
Why?
|
Mutation | 5 | 2023 | 29786 | 0.070 |
Why?
|
Pain Measurement | 1 | 2017 | 3420 | 0.070 |
Why?
|
Lower Extremity | 1 | 2015 | 1158 | 0.070 |
Why?
|
Public Opinion | 1 | 2011 | 477 | 0.070 |
Why?
|
Causality | 1 | 2013 | 1275 | 0.070 |
Why?
|
Membrane Lipids | 1 | 2007 | 249 | 0.070 |
Why?
|
Tumor Microenvironment | 3 | 2024 | 3590 | 0.070 |
Why?
|
Catheter Ablation | 1 | 2019 | 2758 | 0.070 |
Why?
|
Sex Factors | 1 | 2020 | 10400 | 0.070 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 2873 | 0.070 |
Why?
|
Proto-Oncogene Proteins | 1 | 2018 | 4554 | 0.070 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2016 | 2043 | 0.070 |
Why?
|
Arabidopsis Proteins | 1 | 2007 | 262 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 5 | 2021 | 35425 | 0.070 |
Why?
|
Databases, Factual | 4 | 2022 | 7730 | 0.070 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2014 | 1624 | 0.070 |
Why?
|
Histones | 1 | 2016 | 2598 | 0.060 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2016 | 2949 | 0.060 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13991 | 0.060 |
Why?
|
Neck | 1 | 2009 | 698 | 0.060 |
Why?
|
Radiography | 2 | 2019 | 7023 | 0.060 |
Why?
|
Incidence | 4 | 2019 | 20952 | 0.060 |
Why?
|
Cohort Studies | 7 | 2022 | 40559 | 0.060 |
Why?
|
Intraoperative Complications | 1 | 2012 | 1198 | 0.060 |
Why?
|
Cerebral Revascularization | 1 | 2007 | 238 | 0.060 |
Why?
|
Social Class | 2 | 2023 | 1997 | 0.060 |
Why?
|
ATP-Binding Cassette Transporters | 1 | 2007 | 560 | 0.060 |
Why?
|
Arabidopsis | 1 | 2007 | 459 | 0.060 |
Why?
|
Blood Glucose | 1 | 2018 | 6254 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2016 | 2214 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2018 | 3338 | 0.060 |
Why?
|
Biopsy | 1 | 2016 | 6755 | 0.060 |
Why?
|
Insulin | 1 | 2018 | 6582 | 0.060 |
Why?
|
Prospective Studies | 7 | 2022 | 53290 | 0.060 |
Why?
|
Propensity Score | 2 | 2021 | 1781 | 0.060 |
Why?
|
Syndrome | 1 | 2009 | 3252 | 0.060 |
Why?
|
Neoplasm Proteins | 1 | 2016 | 3707 | 0.060 |
Why?
|
Morphine Derivatives | 1 | 2022 | 45 | 0.060 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5321 | 0.050 |
Why?
|
Europe | 2 | 2020 | 3338 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2014 | 10943 | 0.050 |
Why?
|
Single-Cell Analysis | 2 | 2024 | 2182 | 0.050 |
Why?
|
Search Engine | 1 | 2023 | 144 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4285 | 0.050 |
Why?
|
Decompression | 1 | 2021 | 43 | 0.050 |
Why?
|
Finite Element Analysis | 1 | 2023 | 431 | 0.050 |
Why?
|
Foramen Magnum | 1 | 2021 | 36 | 0.050 |
Why?
|
Tumor Burden | 2 | 2018 | 1915 | 0.050 |
Why?
|
Neutrophil Activation | 1 | 2022 | 186 | 0.050 |
Why?
|
Angiography | 1 | 2017 | 1639 | 0.050 |
Why?
|
Cross-Sectional Studies | 4 | 2024 | 25039 | 0.050 |
Why?
|
Athletic Injuries | 1 | 2011 | 1154 | 0.050 |
Why?
|
Odds Ratio | 2 | 2023 | 9849 | 0.050 |
Why?
|
Bone Plates | 1 | 2023 | 468 | 0.050 |
Why?
|
Skull Base | 1 | 2023 | 306 | 0.050 |
Why?
|
Imaging, Three-Dimensional | 2 | 2014 | 4042 | 0.050 |
Why?
|
Narcotics | 1 | 2022 | 343 | 0.050 |
Why?
|
Liver Neoplasms | 1 | 2016 | 4253 | 0.050 |
Why?
|
Nutrition Assessment | 1 | 2023 | 723 | 0.050 |
Why?
|
Magnetic Resonance Angiography | 1 | 2007 | 1443 | 0.040 |
Why?
|
Telecommunications | 1 | 2020 | 80 | 0.040 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2018 | 5223 | 0.040 |
Why?
|
Cerebrovascular Disorders | 1 | 2007 | 1504 | 0.040 |
Why?
|
Training Support | 1 | 2020 | 113 | 0.040 |
Why?
|
Positron-Emission Tomography | 1 | 2016 | 6234 | 0.040 |
Why?
|
Reproducibility of Results | 4 | 2023 | 19905 | 0.040 |
Why?
|
Scopolamine | 1 | 2019 | 99 | 0.040 |
Why?
|
Diphenylamine | 1 | 2018 | 50 | 0.040 |
Why?
|
Los Angeles | 1 | 2019 | 238 | 0.040 |
Why?
|
Demography | 1 | 2024 | 1655 | 0.040 |
Why?
|
SEER Program | 1 | 2024 | 1507 | 0.040 |
Why?
|
Ondansetron | 1 | 2019 | 90 | 0.040 |
Why?
|
Radiotherapy Dosage | 2 | 2016 | 2879 | 0.040 |
Why?
|
Prostatic Neoplasms | 1 | 2021 | 11126 | 0.040 |
Why?
|
Health Promotion | 1 | 2011 | 2205 | 0.040 |
Why?
|
Stromal Cells | 1 | 2024 | 1355 | 0.040 |
Why?
|
Rats | 1 | 2014 | 24252 | 0.040 |
Why?
|
Italy | 1 | 2020 | 832 | 0.040 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 11525 | 0.040 |
Why?
|
United States | 5 | 2024 | 69872 | 0.040 |
Why?
|
Lidocaine | 1 | 2020 | 544 | 0.040 |
Why?
|
Observer Variation | 1 | 2023 | 2593 | 0.040 |
Why?
|
Myeloid Cells | 1 | 2021 | 810 | 0.040 |
Why?
|
Perception | 1 | 2023 | 1198 | 0.030 |
Why?
|
Platelet Count | 1 | 2019 | 780 | 0.030 |
Why?
|
Peripheral Nervous System | 1 | 2017 | 150 | 0.030 |
Why?
|
Focus Groups | 1 | 2021 | 1321 | 0.030 |
Why?
|
Morbidity | 1 | 2021 | 1768 | 0.030 |
Why?
|
Dexmedetomidine | 1 | 2020 | 315 | 0.030 |
Why?
|
Animals | 5 | 2023 | 168768 | 0.030 |
Why?
|
Feedback | 1 | 2019 | 795 | 0.030 |
Why?
|
Child | 5 | 2023 | 77709 | 0.030 |
Why?
|
Natural Language Processing | 1 | 2023 | 1041 | 0.030 |
Why?
|
Necrosis | 1 | 2019 | 1643 | 0.030 |
Why?
|
Walking | 1 | 2022 | 1180 | 0.030 |
Why?
|
Ketamine | 1 | 2020 | 501 | 0.030 |
Why?
|
Income | 1 | 2023 | 1913 | 0.030 |
Why?
|
Dose-Response Relationship, Radiation | 1 | 2016 | 876 | 0.030 |
Why?
|
Cerebrospinal Fluid | 1 | 2017 | 535 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 323 | 0.030 |
Why?
|
Comparative Effectiveness Research | 1 | 2019 | 680 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2021 | 2539 | 0.030 |
Why?
|
Aniline Compounds | 1 | 2018 | 986 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2021 | 16690 | 0.030 |
Why?
|
Patient Preference | 1 | 2021 | 889 | 0.030 |
Why?
|
Severity of Illness Index | 2 | 2021 | 15535 | 0.030 |
Why?
|
Vancomycin | 1 | 2016 | 501 | 0.030 |
Why?
|
Quality Improvement | 2 | 2019 | 3749 | 0.030 |
Why?
|
Triage | 1 | 2020 | 977 | 0.030 |
Why?
|
Mice, SCID | 1 | 2018 | 2716 | 0.030 |
Why?
|
Benzamides | 1 | 2018 | 1379 | 0.030 |
Why?
|
Postoperative Period | 1 | 2018 | 1842 | 0.030 |
Why?
|
Body Weight | 1 | 2023 | 4671 | 0.030 |
Why?
|
Medicine | 1 | 2021 | 946 | 0.030 |
Why?
|
Qualitative Research | 1 | 2021 | 2682 | 0.030 |
Why?
|
Mice, Nude | 1 | 2018 | 3689 | 0.030 |
Why?
|
Dexamethasone | 1 | 2019 | 1951 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2020 | 2307 | 0.030 |
Why?
|
Sarcoidosis | 1 | 2017 | 506 | 0.030 |
Why?
|
Hospitalization | 2 | 2021 | 10259 | 0.020 |
Why?
|
Radiation Injuries | 1 | 2019 | 1180 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2021 | 5077 | 0.020 |
Why?
|
Consensus | 1 | 2020 | 2960 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2018 | 3554 | 0.020 |
Why?
|
Internationality | 1 | 2016 | 1002 | 0.020 |
Why?
|
Health Status | 1 | 2023 | 4034 | 0.020 |
Why?
|
Decision Support Systems, Clinical | 1 | 2019 | 1164 | 0.020 |
Why?
|
Safety | 1 | 2014 | 1186 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2022 | 3486 | 0.020 |
Why?
|
Data Collection | 1 | 2019 | 3339 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2023 | 7785 | 0.020 |
Why?
|
Neutrophils | 1 | 2022 | 3721 | 0.020 |
Why?
|
Health Expenditures | 1 | 2022 | 2349 | 0.020 |
Why?
|
Critical Illness | 1 | 2022 | 2670 | 0.020 |
Why?
|
Sulfonamides | 1 | 2018 | 1940 | 0.020 |
Why?
|
Plant Epidermis | 1 | 2007 | 5 | 0.020 |
Why?
|
Gene Silencing | 1 | 2014 | 1539 | 0.020 |
Why?
|
Waxes | 1 | 2007 | 17 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2023 | 3154 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2024 | 9445 | 0.020 |
Why?
|
Macrophages | 1 | 2021 | 5660 | 0.020 |
Why?
|
Kidney | 1 | 2022 | 7184 | 0.020 |
Why?
|
Risk | 1 | 2019 | 9688 | 0.020 |
Why?
|
Health Personnel | 1 | 2020 | 3219 | 0.020 |
Why?
|
Clinical Competence | 1 | 2022 | 4687 | 0.020 |
Why?
|
Time Factors | 2 | 2019 | 40075 | 0.020 |
Why?
|
Prevalence | 1 | 2023 | 15221 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2023 | 5135 | 0.020 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2021 | 8432 | 0.020 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2007 | 712 | 0.020 |
Why?
|
Microscopy, Electron, Scanning | 1 | 2007 | 963 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2015 | 6896 | 0.020 |
Why?
|
Tuberculosis | 1 | 2017 | 1912 | 0.020 |
Why?
|
Phenotype | 1 | 2022 | 16367 | 0.020 |
Why?
|
Vascular Patency | 1 | 2007 | 887 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2021 | 10183 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21748 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2019 | 15078 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4805 | 0.010 |
Why?
|
Mice, Knockout | 1 | 2018 | 14561 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2020 | 7282 | 0.010 |
Why?
|
Biological Transport | 1 | 2007 | 2120 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6566 | 0.010 |
Why?
|
Electronic Health Records | 1 | 2019 | 4468 | 0.010 |
Why?
|
Apoptosis | 1 | 2018 | 9724 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2016 | 12244 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2017 | 12961 | 0.010 |
Why?
|
Infant | 1 | 2023 | 35134 | 0.010 |
Why?
|
Child, Preschool | 1 | 2023 | 41005 | 0.010 |
Why?
|
Signal Transduction | 1 | 2024 | 23404 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2014 | 11031 | 0.010 |
Why?
|
Fatty Acids | 1 | 2007 | 1809 | 0.010 |
Why?
|
Recombinant Fusion Proteins | 1 | 2007 | 3773 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7182 | 0.010 |
Why?
|
Cerebrovascular Circulation | 1 | 2007 | 2732 | 0.010 |
Why?
|
Alleles | 1 | 2007 | 6933 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2018 | 13693 | 0.010 |
Why?
|
Mice | 1 | 2021 | 81201 | 0.010 |
Why?
|
Brain | 1 | 2017 | 26388 | 0.010 |
Why?
|